Amarin Corporation
Amarin Corporation
Amarin Corporation (pronounced: /æmərɪn kɔːr.pəˈreɪ.ʃən/) is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.
Etymology
The name "Amarin" is derived from the Latin word "amarus" meaning bitter, possibly referring to the bitter taste of some medicinal plants and the challenges faced in the pharmaceutical industry.
History
Amarin Corporation was founded in 1993 and is headquartered in Dublin, Ireland. The company's primary product is Vascepa, a prescription-grade omega-3 fatty acid.
Products
Vascepa
Vascepa (pronounced: /væsˈsiːpə/) is a prescription medication used along with a low-fat and low-cholesterol diet to lower high levels of triglycerides (fats) in adults. It is in a class of medications called lipid-regulating agents. It works by decreasing the amount of triglycerides produced by the body.
Related Terms
- Biopharmaceutical
- Medicinal plants
- Pharmaceutical industry
- Omega-3 fatty acid
- Triglycerides
- Lipid-regulating agents
External links
- Medical encyclopedia article on Amarin Corporation
- Wikipedia's article - Amarin Corporation
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski